Table 1 Baseline characteristics of participants with LVEF and outcomes (N = 445)
Variables | Participants with neither death nor hospitalization for HF at 1 year N = 393 | Participants with death or hospitalization for HF at 1 year N = 52 |
|---|---|---|
Age (mean ± SD, years) | 61 ± 12.1 (393) | 71 ± 13.0 (52) |
Gender, % Male | 75.6 (297) | 69.2 (36) |
White race (vs. non- White race) | 86.7 % (341) | 88.5 % (42) |
Body Mass Index, (mean ± SD, units) | 28.9 ± 6.3 (372) | 27.9 ± 6.0 (42) |
Time from onset of symptoms to treatment (minutes) | ||
Mean ± SD, | 146.8 ± 206.4 (353) | 111.7 ± 109.3 (37) |
median < IQR > | 78 < 50.0–140.0 > | 65 < 40.0–145.0 > |
Chief Complaint on Presentation | ||
Chest Pain | 91.8 % (361) | 84.6 % (44) |
Medical History, % (n) | ||
CAD (MI, PCI or CABG) | 30.8 % (121) | 69.2 % (36) |
Heart Failure | 6.7 % (25) | 23.1 % (12) |
Diabetes Mellitus | 21.1 % (83) | 34.7 % (18) |
Hypertension | 62.3 % (245) | 78.8 % (41) |
Stroke | 5.9 % (23) | 15.4 % (8) |
Hyperlipidemia | 46.8 % (184) | 65.4 % (34) |
Hospital Reperfusion Treatment, %(n) | ||
PCI | 73.8 % (290) | 59.6 % (31) |
Thrombolytic therapy | 0.8 % (3) | 9.6 % (5) |
CABG | 5.1 % (20) | 7.7 % (4) |
Confirmed Diagnosis, % (n) | ||
Acute Myocardial Infarction | 80.4 % (316) | 78.8 % (41) |
Killip Class | ||
1 | 76.1 % (299) | 51.9 % (27) |
2 | 1.8 % (7) | 1.3 % (7) |
3 | 0.5 % (2) | 3.8 % (2) |
4 | 2.0 % (8) | 9.6 % (5) |
Unstable Angina | 12.7 % (50) | 9.6 % (5) |
ECG based findings | ||
ST Elevation on Presentation (ECG) | 70.8 % (264) | 66.0 % (33) |
ACI-TIPI score, (Mean ± SD) | 80.7 ± 17.6 (386) | 84.8 ± 11.2 (49) |
LVEF in %, Median (IQR) | 50 (40,60) | 35 (25,45) |
GIK (vs. Placebo) | 47.6 % (187) | 38.5 % (20) |